Vanta Bioscience Limited (VANTABIO.BO)
INR 24.2
(0.0%)
INR 24.2
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 607.93 Million INR | 6.53% |
| 2022 | 570.64 Million INR | 27.83% |
| 2021 | 446.42 Million INR | 33.98% |
| 2020 | 333.19 Million INR | 94.01% |
| 2019 | 171.74 Million INR | 72.09% |
| 2018 | 99.8 Million INR | -10.02% |
| 2017 | 110.91 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | 607.93 Million INR | 6.7% |
| 2023 FY | 607.93 Million INR | 6.53% |
| 2023 Q2 | 569.76 Million INR | -0.15% |
| 2022 Q4 | 570.64 Million INR | 21.33% |
| 2022 Q2 | 470.31 Million INR | 5.35% |
| 2022 FY | 570.64 Million INR | 27.83% |
| 2021 FY | 446.42 Million INR | 33.98% |
| 2021 Q2 | 365.96 Million INR | 9.83% |
| 2021 Q4 | 446.42 Million INR | 21.99% |
| 2020 Q2 | 202.22 Million INR | 17.75% |
| 2020 FY | 333.19 Million INR | 94.01% |
| 2020 Q4 | 333.19 Million INR | 64.77% |
| 2019 Q4 | 171.74 Million INR | 32.07% |
| 2019 FY | 171.74 Million INR | 72.09% |
| 2019 Q2 | 130.04 Million INR | 30.3% |
| 2018 FY | 99.8 Million INR | -10.02% |
| 2018 Q4 | 99.8 Million INR | -13.23% |
| 2018 Q2 | 115.02 Million INR | 3.7% |
| 2017 FY | 110.91 Million INR | 0.0% |
| 2017 Q4 | 110.91 Million INR | 45.29% |
| 2017 Q2 | 76.33 Million INR | 8.19% |
| 2016 Q4 | 70.55 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 55.127% |
| Biocon Limited | 140.18 Billion INR | 99.566% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 173.163% |
| Concord Biotech Limited | -372.86 Million INR | 263.042% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 96.799% |
| FERMENTA BIOTECH LIMITED | 1.1 Billion INR | 44.955% |
| GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | 1001071.449% |
| Lyka Labs Limited | 527.01 Million INR | -15.354% |
| Panacea Biotec Limited | -1.18 Billion INR | 151.306% |
| SAMSRITA LABS LIMITED | 21.98 Million INR | -2664.665% |
| Servoteach Industries Limited | 5016.00 INR | -12119716.587% |
| SMS Lifesciences India Limited | 992.31 Million INR | 38.736% |
| Supriya Lifescience Limited | -694.68 Million INR | 187.512% |
| Syngene International Limited | -83 Million INR | 832.446% |
| TAKE Solutions Limited | 361.37 Million INR | -68.229% |
| Titan Biotech Limited | 54.62 Million INR | -1012.854% |
| Transgene Biotek Limited | 139.93 Million INR | -334.444% |